95 related articles for article (PubMed ID: 6334986)
1. The effect of age on pathways of drug metabolism in human liver.
Woodhouse KW; Mutch E; Williams FM; Rawlins MD; James OF
Age Ageing; 1984 Nov; 13(6):328-34. PubMed ID: 6334986
[TBL] [Abstract][Full Text] [Related]
2. The effect of alcoholic cirrhosis on the activities of microsomal aldrin epoxidase, 7-ethoxycoumarin O-de-ethylase and epoxide hydrolase, and on the concentrations of reduced glutathione in human liver.
Woodhouse KW; Williams FM; Mutch E; Wright P; James OF; Rawlins MD
Br J Clin Pharmacol; 1983 Jun; 15(6):667-72. PubMed ID: 6603231
[TBL] [Abstract][Full Text] [Related]
3. The effect of age upon the affinity of microsomal mono-oxygenase enzymes for substrate in human liver.
Wynne HA; Mutch E; James OF; Wright P; Rawlins MD; Woodhouse KW
Age Ageing; 1988 Nov; 17(6):401-5. PubMed ID: 3266441
[TBL] [Abstract][Full Text] [Related]
4. Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation.
Meier PJ; Mueller HK; Dick B; Meyer UA
Gastroenterology; 1983 Sep; 85(3):682-92. PubMed ID: 6603386
[TBL] [Abstract][Full Text] [Related]
5. Drug metabolism in skin. Comparative activity of the mixed-function oxidases, epoxide hydratase, and glutathione S-transferase in liver and skin of the neonatal rat.
Mukhtar H; Bickers DR
Drug Metab Dispos; 1981; 9(4):311-4. PubMed ID: 6114828
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferases in the metabolism of foreign compounds.
Hayakawa T
Ecotoxicol Environ Saf; 1977 Dec; 1(3):305-9. PubMed ID: 361374
[No Abstract] [Full Text] [Related]
7. Drug metabolising activity of freshly isolated human hepatocytes.
Tee LB; Seddon T; Boobis AR; Davies DS
Br J Clin Pharmacol; 1985 Mar; 19(3):279-94. PubMed ID: 3872672
[TBL] [Abstract][Full Text] [Related]
8. The effect of alcoholic cirrhosis on the two kinetic components (high and low affinity) of the microsomal 0-deethylation of 7-ethoxycoumarin in human liver.
Woodhouse KW; Williams FM; Mutch E; Wright P; James OF; Rawlins MD
Eur J Clin Pharmacol; 1984; 26(1):61-4. PubMed ID: 6609077
[TBL] [Abstract][Full Text] [Related]
9. The development of hepatic drug-metabolizing enzyme activity in the neonatal calf and its effect on drug disposition.
Shoaf SE; Schwark WS; Guard CL; Babish JG
Drug Metab Dispos; 1987; 15(5):676-81. PubMed ID: 2891486
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the formation of chemically reactive drug metabolites by human liver microsomes.
Kitteringham NR; Lambert C; Maggs JL; Colbert J; Park BK
Br J Clin Pharmacol; 1988 Jul; 26(1):13-21. PubMed ID: 3264509
[TBL] [Abstract][Full Text] [Related]
11. Piperine effects on the expression of P4502E1, P4502B and P4501A in rat.
Kang MH; Won SM; Park SS; Kim SG; Novak RF; Kim ND
Xenobiotica; 1994 Dec; 24(12):1195-204. PubMed ID: 7771106
[TBL] [Abstract][Full Text] [Related]
12. Tissue distribution of drug-metabolizing enzymes in humans.
Pacifici GM; Franchi M; Bencini C; Repetti F; Di Lascio N; Muraro GB
Xenobiotica; 1988 Jul; 18(7):849-56. PubMed ID: 3140501
[TBL] [Abstract][Full Text] [Related]
13. Effect of tamoxifen treatment on liver, lung and intestinal mixed-function oxidases in male and female rats.
Al-Turk WA; Stohs SJ; Roche EB
Drug Metab Dispos; 1981; 9(4):327-30. PubMed ID: 6114831
[TBL] [Abstract][Full Text] [Related]
14. Induction of rat liver microsomal epoxide hydrolase by its endogenous substrate 16 alpha, 17 alpha-epoxyestra-1,3,5-trien-3-ol.
Fändrich F; Degiuli B; Vogel-Bindel U; Arand M; Oesch F
Xenobiotica; 1995 Mar; 25(3):239-44. PubMed ID: 7618350
[TBL] [Abstract][Full Text] [Related]
15. Vinylidene chloride: changes in drug-metabolizing enzymes, mutagenicity and relation to its targets for carcinogenesis.
Oesch F; Protić-Sabljić M; Friedberg T; Klimisch HJ; Glatt HR
Carcinogenesis; 1983 Aug; 4(8):1031-8. PubMed ID: 6347425
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of carbamazepine and its epoxide metabolite in human and rat liver in vitro.
Tybring G; von Bahr C; Bertilsson L; Collste H; Glaumann H; Solbrand M
Drug Metab Dispos; 1981; 9(6):561-4. PubMed ID: 6120817
[TBL] [Abstract][Full Text] [Related]
17. The inducing and inhibiting effects of sodium valproate in vivo on the biotransformation systems of xenobiotics in isolated rat hepatocytes.
Rogiers V; Vandenberghe Y; Callaerts A; Sonck W; Maes V; Vercruysse A
Xenobiotica; 1988 Jun; 18(6):665-73. PubMed ID: 3138827
[TBL] [Abstract][Full Text] [Related]
18. Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
Golan MD; Bücker M; Schmassmann HU; Raphael D; Jung R; Bindel U; Brase HO; Tegtmeyer F; Friedberg T; Lorenz J; Stasiecki P; Oesch F
Drug Metab Dispos; 1980; 8(3):121-6. PubMed ID: 6104571
[No Abstract] [Full Text] [Related]
19. Effect of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice: studies on the mechanism of its anticarcinogenic action.
Das M; Bickers DR; Mukhtar H
Carcinogenesis; 1985 Oct; 6(10):1409-13. PubMed ID: 3876174
[TBL] [Abstract][Full Text] [Related]
20. Effect of protein deficiency on the hepatic microsomal mixed function oxidase. III-Influence on aflatoxin B1 metabolism and epoxide hydrase activity.
Adekunle AA; Hayes JR; Campbell TC
Biochem Exp Biol; 1978; 14(1):45-53. PubMed ID: 105748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
